Short answer
ASP Isotopes Inc. (ASPI) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Shareholder Letter contains forward-looking statements under the PSLRA safe harbor.
ASP Isotopes Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Shareholder Letter contains forward-looking statements under the PSLRA safe harbor
- Investor focus should remain on the accompanying letter for any 2026 operating results or outlook disclosed therein
Item EX-99.1 · Exhibit EX-99.1
- PET Labs 1H 2026 organic revenue growth exceeded 50%; FY 2026 revenue forecast approximately $14 million versus $6 million in 2025
- Renergen helium production targeted before September 30, 2026, with Phase 1 annualized revenue forecast above $27 million
- Phase 2 expected to receive approximately $750 million senior debt funding, subject to definitive agreements
- Noble Africa reverse merger could create Nasdaq-listed helium company; ASPI expected to retain approximately 89% ownership
- Management reiterates 2031 EBITDA target above $300 million, but projections remain subject to execution and unavailable GAAP reconciliation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ASP Isotopes Inc. 8-K filings
Get the next ASPI 8-K as it lands
Follow ASPI for push alerts, or ask the research agent what this filing means.